Wuhan Zhongyuan Huadian Science & Technology (300018.SZ) predicts a net profit of 75.14 million to 87.76 million yuan for the year, an increase of 25% to 46% compared to the previous year.
Zhongyuan Shares (300018.SZ) disclosed its performance forecast for the year 2024, with the company expecting the net profit attributable to shareholders of the listed company to be...
Wuhan Zhongyuan Huadian Science & Technology (300018.SZ) disclosed its performance forecast for the year 2024, with the company expecting a net profit attributable to shareholders of the listed company of 75.14 million to 87.7654 million yuan, a year-on-year increase of 25% to 46%; after deducting non-recurring gains and losses, the net profit is expected to be 75.6199 million to 88.5834 million yuan, a year-on-year increase of 110% to 146%.
Related Articles
IlgANN 2025: Recent real-world research on Nufekang confirms the long-term effectiveness and safety of treatment in the treatment of certain conditions.
Dongfang Electric Corporation (01072) plans to offer a 7.98% discount on the sale of 68 million shares, with a net raise of approximately 1.075 billion Hong Kong dollars.
WEIMOB INC (02013) plans to discount approximately 8.87% of the total issued shares of 6.88 billion subscription shares, raising approximately 1.55 billion HKD.
IlgANN 2025: Recent real-world research on Nufekang confirms the long-term effectiveness and safety of treatment in the treatment of certain conditions.
Dongfang Electric Corporation (01072) plans to offer a 7.98% discount on the sale of 68 million shares, with a net raise of approximately 1.075 billion Hong Kong dollars.
WEIMOB INC (02013) plans to discount approximately 8.87% of the total issued shares of 6.88 billion subscription shares, raising approximately 1.55 billion HKD.
